{"id":"https://openalex.org/W2018538802","doi":"https://doi.org/10.1038/sj.bjc.6600143","title":"A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug","display_name":"A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug","publication_year":2002,"publication_date":"2002-02-26","ids":{"openalex":"https://openalex.org/W2018538802","doi":"https://doi.org/10.1038/sj.bjc.6600143","mag":"2018538802","pmid":"https://pubmed.ncbi.nlm.nih.gov/11875747","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2375299"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjc.6600143","doi":"https://doi.org/10.1038/sj.bjc.6600143","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6600143","pdf_url":"https://www.nature.com/articles/6600143.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/6600143.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"M de Graaf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"M de Graaf","raw_affiliation_strings":["Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands. M.de_Graaf.oncol@med.vu.nl","Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands. M.de_Graaf.oncol@med.vu.nl","institution_ids":["https://openalex.org/I911458345"]},{"raw_affiliation_string":"Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088663155","display_name":"Epie Boven","orcid":"https://orcid.org/0000-0001-9287-743X","observed_orcids":["https://orcid.org/0000-0001-9287-743X"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"E Boven","raw_affiliation_strings":["Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, PO Box 7057, Amsterdam, 1007 MB, The Netherlands","Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, PO Box 7057, Amsterdam, 1007 MB, The Netherlands","institution_ids":["https://openalex.org/I911458345"]},{"raw_affiliation_string":"Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059098786","display_name":"Dinja Oosterhoff","orcid":"https://orcid.org/0000-0001-8707-2266","observed_orcids":["https://orcid.org/0000-0001-8707-2266"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"D Oosterhoff","raw_affiliation_strings":["Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, PO Box 7057, Amsterdam, 1007 MB, The Netherlands","Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, PO Box 7057, Amsterdam, 1007 MB, The Netherlands","institution_ids":["https://openalex.org/I911458345"]},{"raw_affiliation_string":"Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026264825","display_name":"Ida H. van der Meulen\u2010Muileman","orcid":"https://orcid.org/0000-0002-3821-9927","observed_orcids":["https://orcid.org/0000-0002-3821-9927"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"I H van der Meulen-Muileman","raw_affiliation_strings":["Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, PO Box 7057, Amsterdam, 1007 MB, The Netherlands","Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, PO Box 7057, Amsterdam, 1007 MB, The Netherlands","institution_ids":["https://openalex.org/I911458345"]},{"raw_affiliation_string":"Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033586033","display_name":"Gerwin A Huls","orcid":"https://orcid.org/0009-0001-6789-6433","observed_orcids":["https://orcid.org/0009-0001-6789-6433"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"G A Huls","raw_affiliation_strings":["Department of Immunology, Utrecht Medical Centre, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Utrecht Medical Centre, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039709555","display_name":"Winald R. Gerritsen","orcid":"https://orcid.org/0000-0003-1110-9119","observed_orcids":["https://orcid.org/0000-0003-1110-9119"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"W R Gerritsen","raw_affiliation_strings":["Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, PO Box 7057, Amsterdam, 1007 MB, The Netherlands","Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, PO Box 7057, Amsterdam, 1007 MB, The Netherlands","institution_ids":["https://openalex.org/I911458345"]},{"raw_affiliation_string":"Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021729725","display_name":"Hidde J. Haisma","orcid":"https://orcid.org/0000-0003-3997-9052","observed_orcids":["https://orcid.org/0000-0003-3997-9052"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"H J Haisma","raw_affiliation_strings":["Department of Therapeutic Gene Modulation, University Centre for Pharmacy, University of Groningen, PO Box 196, Groningen, 9700 AD, The Netherlands","Department of Therapeutic Gene Modulation, University Centre for Pharmacy, University of Groningen, Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Therapeutic Gene Modulation, University Centre for Pharmacy, University of Groningen, PO Box 196, Groningen, 9700 AD, The Netherlands","institution_ids":["https://openalex.org/I169381384"]},{"raw_affiliation_string":"Department of Therapeutic Gene Modulation, University Centre for Pharmacy, University of Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105878379","display_name":"Herbert M. Pinedo","orcid":"https://orcid.org/0000-0002-8980-371X","observed_orcids":["https://orcid.org/0000-0002-8980-371X"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"H M Pinedo","raw_affiliation_strings":["Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, PO Box 7057, Amsterdam, 1007 MB, The Netherlands","Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, PO Box 7057, Amsterdam, 1007 MB, The Netherlands","institution_ids":["https://openalex.org/I911458345"]},{"raw_affiliation_string":"Department of Medical Oncology, Division of Gene Therapy, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I911458345"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":0.8432,"has_fulltext":true,"cited_by_count":33,"citation_normalized_percentile":{"value":0.70206649,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"86","issue":"5","first_page":"811","last_page":"818"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8026999831199646,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8026999831199646,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.15299999713897705,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.010700000450015068,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epcam","display_name":"EpCAM","score":0.925000011920929},{"id":"https://openalex.org/keywords/single-chain-variable-fragment","display_name":"scFv","score":0.7200000286102295},{"id":"https://openalex.org/keywords/beta-glucuronidase","display_name":"beta-glucuronidase","score":0.8939999938011169},{"id":"https://openalex.org/keywords/fusion-protein","display_name":"fusion protein","score":0.878000020980835},{"id":"https://openalex.org/keywords/doxorubicin-prodrug","display_name":"doxorubicin prodrug","score":0.9150000214576721},{"id":"https://openalex.org/keywords/targeted-chemotherapy","display_name":"targeted chemotherapy","score":0.7390000224113464},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.7310000061988831},{"id":"https://openalex.org/keywords/bystander-effect","display_name":"bystander effect","score":0.9039999842643738}],"concepts":[{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.7571387887001038},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.635267972946167},{"id":"https://openalex.org/C2778556491","wikidata":"https://www.wikidata.org/wiki/Q1660173","display_name":"Immunoconjugate","level":4,"score":0.6303884983062744},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.5701733231544495},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5376613736152649},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.45999252796173096},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.45863640308380127},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.442516028881073},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3833238482475281},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.366097629070282},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.2910499572753906},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.09187200665473938},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.07350939512252808},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000071858","descriptor_name":"Epithelial Cell Adhesion Molecule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005966","descriptor_name":"Glucuronidase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D005966","descriptor_name":"Glucuronidase","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D005966","descriptor_name":"Glucuronidase","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008222","descriptor_name":"Lymphokines","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008222","descriptor_name":"Lymphokines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008222","descriptor_name":"Lymphokines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011786","descriptor_name":"Quality Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012795","descriptor_name":"Sialoglycoproteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012795","descriptor_name":"Sialoglycoproteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012795","descriptor_name":"Sialoglycoproteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015815","descriptor_name":"Cell Adhesion Molecules","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015815","descriptor_name":"Cell Adhesion Molecules","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015815","descriptor_name":"Cell Adhesion Molecules","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016133","descriptor_name":"Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024201","descriptor_name":"Bystander Effect","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1038/sj.bjc.6600143","doi":"https://doi.org/10.1038/sj.bjc.6600143","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6600143","pdf_url":"https://www.nature.com/articles/6600143.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:11875747","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11875747","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2375299","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2375299/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmh:oai:pure.rug.nl:openaire/55e537de-7577-4e25-9a2c-bafda0114468","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/55e537de-7577-4e25-9a2c-bafda0114468","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Boven, E, Oosterhoff, D, van der Meulen-Muileman, IH, Huls, GA, Gerritsen, WR, Haisma, HJ & Pinedo, HM 2002, 'A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug', British Jounal of Cancer, vol. 86, no. 5, pp. 811-818. https://doi.org/10.1038/sj/bjc/6600143","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/55e537de-7577-4e25-9a2c-bafda0114468","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/55e537de-7577-4e25-9a2c-bafda0114468","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Jounal of Cancer, 86(5), 811 - 818. Nature Publishing Group","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/884d820e-883d-459c-90c7-c4091c2dfea9","doi":null,"is_oa":false,"landing_page_url":"https://www.rug.nl/research/portal/en/publications/a-fully-human-antiepcam-scfvbetaglucuronidase-fusion-protein-for-selective-chemotherapy-with-a-glucuronide-prodrug(884d820e-883d-459c-90c7-c4091c2dfea9).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Jounal of Cancer, 86(5), 811 - 818","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1038/sj.bjc.6600143","doi":"https://doi.org/10.1038/sj.bjc.6600143","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6600143","pdf_url":"https://www.nature.com/articles/6600143.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2018538802.pdf","grobid_xml":"https://content.openalex.org/works/W2018538802.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W68282923","https://openalex.org/W1502767888","https://openalex.org/W1877082552","https://openalex.org/W1915689252","https://openalex.org/W1965348791","https://openalex.org/W1981793850","https://openalex.org/W1983748607","https://openalex.org/W1993759349","https://openalex.org/W2003977399","https://openalex.org/W2011729980","https://openalex.org/W2018289835","https://openalex.org/W2027237423","https://openalex.org/W2029925637","https://openalex.org/W2041375044","https://openalex.org/W2041623801","https://openalex.org/W2050314327","https://openalex.org/W2067515443","https://openalex.org/W2096743918","https://openalex.org/W2098255750","https://openalex.org/W2100837269","https://openalex.org/W2101585839","https://openalex.org/W2108247477","https://openalex.org/W2134640618","https://openalex.org/W2143088883","https://openalex.org/W2154027407","https://openalex.org/W2155392902","https://openalex.org/W2169693919","https://openalex.org/W2280071310","https://openalex.org/W2319203375","https://openalex.org/W2319558635","https://openalex.org/W2327310363","https://openalex.org/W2402287483","https://openalex.org/W2418702086","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2280071310","https://openalex.org/W2098255750","https://openalex.org/W2011729980","https://openalex.org/W2562877688","https://openalex.org/W2112913022","https://openalex.org/W4243997305","https://openalex.org/W1979430403","https://openalex.org/W2320091911","https://openalex.org/W2079489226","https://openalex.org/W202158015"],"abstract_inverted_index":{"Monoclonal":[0],"antibodies":[1],"against":[2,57,193],"tumour-associated":[3],"antigens":[4],"could":[5],"be":[6,30,40],"useful":[7],"to":[8,12,105,139,148],"deliver":[9],"enzymes":[10],"selectively":[11],"the":[13,58,64,89,96,118,173,176,181],"site":[14],"of":[15,20,49,95,128,144,172,190,208],"a":[16,21,45,50,79,82,141,209],"tumour":[17],"for":[18,32,93,202],"activation":[19,207],"non-toxic":[22,142,210],"prodrug.":[23,212],"A":[24,99,153],"completely":[25],"human":[26,51,65,73,184,199],"fusion":[27,46,97,108,120,135,177,187],"protein":[28,47,121,136,188],"may":[29,39],"advantageous":[31],"repeated":[33],"administration,":[34],"as":[35,158],"host":[36],"immune":[37],"responses":[38],"avoided.":[41],"We":[42],"have":[43],"constructed":[44],"consisting":[48,189],"single":[52],"chain":[53],"Fv":[54],"antibody,":[55],"C28,":[56],"epithelial":[59,194],"cell":[60,101,195],"adhesion":[61,196],"molecule":[62,197],"and":[63,72,85,112,185,198],"enzyme":[66,74,113,200],"beta-glucuronidase.":[67],"The":[68,134],"sequences":[69],"encoding":[70,81],"C28":[71],"beta-glucuronidase":[75,201],"were":[76,86,115],"joined":[77],"by":[78,88],"sequence":[80,92],"flexible":[83],"linker,":[84],"preceded":[87],"IgGkappa":[90],"signal":[91],"secretion":[94],"protein.":[98,109,178],"CHO":[100],"line":[102],"was":[103,137,156,160],"engineered":[104],"secrete":[106],"C28-beta-glucuronidase":[107],"Antibody":[110],"specificity":[111],"activity":[114],"retained":[116],"in":[117,151,162,205],"secreted":[119],"that":[122],"had":[123],"an":[124,191],"apparent":[125],"molecular":[126],"mass":[127],"100":[129],"kDa":[130],"under":[131],"denaturing":[132],"conditions.":[133],"able":[138],"convert":[140],"prodrug":[143],"doxorubicin,":[145,149],"N-[4-doxorubicin-N-carbonyl(oxymethyl)phenyl]-O-beta-glucuronyl":[146,166],"carbamate":[147,167],"resulting":[150],"cytotoxicity.":[152],"bystander":[154],"effect":[155],"demonstrated,":[157],"doxorubicin":[159],"detected":[161],"all":[163],"cells":[164,174],"after":[165],"administration":[168],"when":[169],"only":[170],"10%":[171],"expressed":[175],"This":[179],"is":[180],"first":[182],"fully":[183],"functional":[186],"scFv":[192],"future":[203],"use":[204],"tumour-specific":[206],"glucuronide":[211]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}